Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Sonpavde, Guru
Item TypeName
Academic Article Systemic chemotherapy for urothelial cancer.
Academic Article ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
Academic Article Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
Academic Article Novel agents for muscle-invasive and advanced urothelial cancer.
Academic Article A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Academic Article A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancer.
Academic Article Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium.
Academic Article Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
Academic Article New perspectives in the therapy of castration resistant prostate cancer.
Academic Article Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis.
Academic Article Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Academic Article Recent advances in immunotherapy for the treatment of prostate cancer.
Academic Article The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature.
Academic Article Novel molecular targets for the therapy of renal cell carcinoma.
Academic Article Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.
Academic Article Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.
Academic Article Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
Academic Article Immunotherapy for castration-resistant prostate cancer.
Academic Article Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma.
Academic Article Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
Academic Article Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.
Academic Article Problems with the randomized discontinuation design.
Academic Article The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients.
Academic Article Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma.
Academic Article Novel agents for advanced bladder cancer.
Academic Article Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?
Academic Article The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.
Academic Article Hormone refractory prostate cancer: Management and advances.
Academic Article Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.
Concept Breast Neoplasms
Concept Bone Neoplasms
Concept Ureteral Neoplasms
Concept Neoplasms, Hormone-Dependent
Concept Head and Neck Neoplasms
Concept Immunotherapy, Active
Concept Mediastinal Neoplasms
Concept Urogenital Neoplasms
Concept Colorectal Neoplasms
Concept Cancer Vaccines
Concept Genital Neoplasms, Male
Concept Penile Neoplasms
Concept Kidney Neoplasms
Concept Neoplasms, Multiple Primary
Concept Muscle Neoplasms
Concept Immunotherapy
Concept Lung Neoplasms
Concept Neoplasms
Concept Early Detection of Cancer
Concept Urologic Neoplasms
Concept Neoplasms, Germ Cell and Embryonal
Concept Testicular Neoplasms
Concept Liver Neoplasms
Concept Prostatic Neoplasms
Concept Urethral Neoplasms
Concept Retroperitoneal Neoplasms
Concept Urinary Bladder Neoplasms
Academic Article Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors.
Academic Article Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
Academic Article Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer.
Academic Article Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy.
Academic Article Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Academic Article Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors.
Academic Article Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer.
Academic Article Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
Academic Article Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.
Academic Article Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.
Academic Article The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.
Academic Article Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments.
Academic Article A new approach to second-line therapy for urothelial cancer?
Academic Article Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis of randomized clinical trials.
Academic Article Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma.
Academic Article Metabolic complications with the use of mTOR inhibitors for cancer therapy.
Academic Article Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design.
Academic Article Precision medicine for metastatic renal cell carcinoma.
Academic Article Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.
Academic Article Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
Academic Article A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
Academic Article Prostate cancer, version 2.2014.
Academic Article Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.
Academic Article Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.
Academic Article New agents for prostate cancer.
Academic Article Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
Academic Article Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.
Academic Article Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design.
Academic Article Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer.
Academic Article Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials.
Academic Article Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials.
Academic Article Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.
Academic Article Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?
Academic Article Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy.
Academic Article An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.
Academic Article QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Academic Article Future directions and targeted therapies in bladder cancer.
Academic Article Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design.
Academic Article Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.
Academic Article A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma.
Academic Article Precision and predictive medicine in urothelial cancer: are we making progress?
Academic Article High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes.
Academic Article Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
Academic Article Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.
Academic Article Prostate Cancer, Version 1.2016.
Academic Article Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma.
Academic Article Docetaxel for Castration-sensitive Prostate Cancer: Wrapping up Unfinished Business?
Academic Article Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
Academic Article Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer--At What Cost? Eur Urol 2016;69:642-44: Combination Chemotherapy as a Viable Salvage Therapy Strategy for Advanced Urothelial Carcinoma.
Academic Article The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.
Academic Article Bladder cancer: Angiogenesis as a therapeutic target in urothelial carcinoma.
Academic Article Ruffling the Immunotherapy Response Paradigm with a Novel Personalized Peptide Vaccine.
Academic Article Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Academic Article Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.
Academic Article Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy.
Academic Article NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
Academic Article Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Academic Article Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.
Academic Article Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Academic Article Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.
Academic Article Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma.
Academic Article From the Uncertainties to the Evidence: A Brief History of Immunotherapy as Salvage Therapy for Advanced Bladder Cancer Through a Meta-analysis.
Academic Article Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
Academic Article Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
Academic Article Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
Academic Article Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article JAVELIN: avelumab another spear to fight urothelial carcinoma.
Academic Article The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
Academic Article Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
Academic Article Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma.
Academic Article Administration of cisplatin-based chemotherapy for advanced urothelial carcinoma in the community.
Academic Article Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Academic Article Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer.
Academic Article Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the Bladder.
Academic Article Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices.
Academic Article Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.
Academic Article Axitinib for renal cell carcinoma.
Academic Article Lapatinib plus capecitabine in breast cancer.
Academic Article Perioperative chemotherapy for bladder cancer.
Academic Article Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Academic Article Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin.
Academic Article Emerging Systemic Therapies for the Management of Penile Cancer.
Academic Article Prevalence of Measurable Disease in Metastatic Castration-resistant Prostate Cancer.
Academic Article Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.
Academic Article Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.
Academic Article Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.
Academic Article First-line systemic therapy trials for advanced transitional-cell carcinoma of the urothelium: should we stop separating cisplatin-eligible and -ineligible patients?
Academic Article Satraplatin for the therapy of castration-resistant prostate cancer.
Academic Article The role of docetaxel based therapy for prostate cancer in the era of targeted medicine.
Academic Article Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
Academic Article Prostatectomy or watchful waiting in prostate cancer.
Academic Article Hypomethylating agents for urologic cancers.
Academic Article Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
Academic Article Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer.
Academic Article The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer.
Academic Article Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.
Academic Article Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?
Academic Article Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma.
Academic Article Pazopanib for the treatment of renal cell carcinoma and other malignancies.
Academic Article Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.
Academic Article Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Academic Article Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer.
Academic Article Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trial.
Academic Article Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.
Academic Article Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.
Academic Article Tivozanib for the treatment of renal cell carcinoma: results and implications of the TIVO-1 trial.
Academic Article Cabazitaxel for the treatment of castration-resistant prostate cancer.
Academic Article Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Academic Article Contemporary management of metastatic castration-resistant prostate cancer.
Academic Article Systemic Therapy for Urothelial Carcinoma: Is a Renaissance Around the Corner?
Academic Article Bevacizumab for non-small-cell lung cancer.
Academic Article Emerging drugs for urothelial carcinoma.
Academic Article Taxane-based Combination Therapies for Metastatic Prostate Cancer.
Academic Article Trial design for metastatic castration-resistant prostate cancer.
Academic Article Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
Academic Article Recent advances in the therapy of renal cancer.
Academic Article Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Academic Article Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline.
Academic Article Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
Academic Article The expanding role of chemotherapy in prostate cancer.
Academic Article Epigenetics in prostate cancer.
Academic Article Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer.
Academic Article Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.
Academic Article Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis.
Academic Article Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Academic Article Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
Academic Article The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma.
Academic Article Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma.
Academic Article Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Academic Article Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial.
Academic Article The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma.
Academic Article The Neoadjuvant Paradigm for Development of Systemic Therapy and Precision Medicine for Bladder Cancer.
Academic Article The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.
Academic Article Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Academic Article Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
Academic Article Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials.
Academic Article Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trials.
Academic Article Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.
Academic Article Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective Studies.
Academic Article Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
Academic Article A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma.
Academic Article miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
Academic Article Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.
Academic Article Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
Academic Article Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients.
Academic Article Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer.
Academic Article Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States.
Academic Article Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Academic Article Novel molecular targets for the therapy of castration-resistant prostate cancer.
Academic Article Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.
Academic Article Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
Academic Article Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer.
Academic Article Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
Academic Article Abiraterone and increased survival in metastatic prostate cancer.
Academic Article New approaches in hormone refractory prostate cancer.
Academic Article Which checkpoint inhibitor? An embarrassment of riches for bladder cancer.
Academic Article Circulating Tumor Cells in Advanced Prostate Cancer: Time to Move from Prognostic to Predictive Ability.
Academic Article The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer.
Academic Article PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma.
Academic Article Corticosteroids in the management of prostate cancer: a critical review.
Academic Article Editorial Comment.
Academic Article Optimal management of metastatic renal cell carcinoma: current status.
Academic Article Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study.
Academic Article Vaccine therapy in renal cell carcinoma: attempting to leap over a rising bar.
Academic Article GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
Academic Article Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
Academic Article Chemotherapy for bladder cancer.
Academic Article Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis.
Academic Article Circulating Biomarkers in Bladder Cancer.
Academic Article Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials.
Academic Article Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.
Academic Article Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.
Academic Article Management of recurrent testicular germ cell tumors.
Academic Article Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.
Academic Article Immunotherapy of advanced renal cell carcinoma: Current and future therapies.
Academic Article The biology of prostate cancer metastases: does oligo differ from polymetastatic?
Academic Article Neoadjuvant chemotherapy for bladder cancer.
Academic Article Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
Academic Article Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies.
Academic Article Update in systemic therapy of urologic malignancies.
Academic Article Objective measures of physical functional capacity warrant exploration to complement or replace the subjective physician estimated performance status.
Academic Article Emerging vaccine therapy approaches for prostate cancer.
Academic Article PSA and clinical responses to celecoxib in a patient with prostate cancer and bone metastases.
Academic Article Bevacizumab in colorectal cancer.
Academic Article Peg-filgrastim and cabazitaxel in prostate cancer patients.
Academic Article Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage.
Academic Article Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.
Academic Article Update of systemic immunotherapy for advanced urothelial carcinoma.
Academic Article Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 2. Rhabdomyosarcoma of the urinary bladder in an adult.
Academic Article Neoadjuvant systemic therapy for urological malignancies.
Academic Article Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.
Academic Article Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Academic Article Emerging agents for the therapy of advanced prostate cancer.
Academic Article Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.
Academic Article Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
Academic Article Objective evaluation of bone metastases in prostate cancer: to what end?
Academic Article Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC).
Academic Article Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy.
Academic Article Bladder cancer update. Current evaluation methods and standard of care.
Academic Article Trends in the use of cytoreductive nephrectomy in the United States.
Academic Article Patients with unusual bladder malignancies and a rare cause of splenomegaly. Case 1. Small-cell carcinoma of the urinary bladder.
Academic Article Current optimal chemotherapy for advanced urothelial cancer.
Academic Article Drug development in prostate cancer: time to embrace RECIST?
Academic Article Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy.
Academic Article CD24 is a genetic modifier for risk and progression of prostate cancer.
Academic Article Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.
Academic Article Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployed.
Academic Article Breast-conserving surgery for breast cancer.
Academic Article PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study.
Academic Article Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.
Academic Article Germ-cell tumors.
Academic Article pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
Academic Article Pazopanib: a novel multitargeted tyrosine kinase inhibitor.
Academic Article Radical prostatectomy versus watchful waiting.
Academic Article Neoadjuvant chemotherapy for invasive bladder cancer.
Academic Article Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel.
Academic Article Abiraterone acetate for metastatic prostate cancer.
Academic Article The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.
Academic Article Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
Academic Article Clinical and pharmacokinetic evaluation of satraplatin.
Academic Article Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Academic Article The impact of gender on outcomes in patients with metastatic urothelial carcinoma.
Academic Article Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
Academic Article Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling.
Academic Article Bevacizumab in renal-cell cancer.
Academic Article Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.
Academic Article Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.
Academic Article Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Academic Article Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.
Academic Article Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?
Academic Article Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis.
Academic Article Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
Academic Article Treatment of advanced head and neck cancer.
Academic Article Current preclinical models for the advancement of translational bladder cancer research.
Academic Article Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: a meta-analysis.
Academic Article Docetaxel for the treatment of bladder cancer.
Academic Article Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma.
Academic Article The preclinical activity of lenalidomide in indolent urothelial carcinoma.
Academic Article Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate.
Academic Article Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Academic Article Diagnosis and management of urothelial carcinoma of the bladder.
Academic Article Novel antiangiogenic agents in the treatment of refractory renal cell carcinoma.
Academic Article Words of Wisdom. Re: Androgen Deprivation Therapy plus Docetaxel and Estramustine Versus Androgen Deprivation Therapy Alone for High-risk Localised Prostate Cancer (GETUG 12): A Phase 3 Randomised Controlled Trial.
Academic Article Vaccine therapy for prostate cancer.
Academic Article Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials.
Academic Article HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
Academic Article Intracranial meningeal carcinomatosis in metastatic castration resistant prostate cancer: will extension of survival increase the incidence?
Academic Article Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study.
Academic Article Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: the international retrospective observational STABEN study.
Academic Article Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
Academic Article Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States.
Academic Article Immunotherapy for Renal Cancer: Sequencing and Combinations.
Academic Article Promising immunotherapy for prostate cancer.
Academic Article Can RECIST response predict success in phase 3 trials in men with metastatic castration-resistant prostate cancer?
Academic Article Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.
Academic Article Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma.
Academic Article Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.
Academic Article A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
Academic Article Immunotherapy for advanced penile cancer - rationale and potential.
Academic Article An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
Academic Article SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
Academic Article Treating Patients With Bladder Cancer: Is There an Ethical Obligation to Include Smoking Cessation Counseling?
Academic Article Systemic treatments for metastatic urothelial carcinoma.
Academic Article Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories.
Academic Article Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Academic Article Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
Academic Article Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.
Academic Article Penile cancer: current therapy and future directions.
Academic Article Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes.
Academic Article Ketoconazole retains activity in patients with docetaxel-refractory prostate cancer.
Academic Article Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
Academic Article Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Academic Article Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Academic Article Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer.
Academic Article C-statistic: A brief explanation of its construction, interpretation and limitations.
Academic Article Tissue-based molecular markers for bladder cancer.
Academic Article Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.
Academic Article Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial.
Academic Article Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.
Academic Article What to do when you discover testicular cancer. Helping patients overcome fear and choose treatment.
Academic Article Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
Academic Article Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC.
Academic Article Antileukemic activity of Flt3 ligand in murine leukemia.
Academic Article Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer.
Academic Article Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection.
Academic Article Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis.
Academic Article Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor.
Academic Article Rare Genitourinary Malignancies: Current Status and Future Directions of Immunotherapy.
Academic Article Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
Academic Article Conceptual Framework for Therapeutic Development Beyond Anti-PD-1/PD-L1 in Urothelial Cancer.
Academic Article Role of Checkpoint Inhibition in Localized Bladder Cancer.
Academic Article Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Academic Article Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Academic Article Advanced urothelial cancer: a radiology update.
Academic Article A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer.
Academic Article Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials.
Academic Article Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors.
Academic Article Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer.
Academic Article Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma.
Academic Article Investigational MET inhibitors to treat Renal cell carcinoma.
Academic Article Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy.
Academic Article Erdafitinib in Urothelial Carcinoma.
Academic Article Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Academic Article Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
Academic Article Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.
Academic Article ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.
Academic Article Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Academic Article A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Academic Article Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
Academic Article Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
Academic Article PGC1a suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression.
Academic Article The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing.
Academic Article Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor.
Academic Article A CD24-p53 axis contributes to African American prostate cancer disparities.
Academic Article Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.
Academic Article PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region.
Academic Article Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
Academic Article Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
Academic Article Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors.
Academic Article Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
Academic Article Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
Academic Article Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
Academic Article Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
Academic Article Neoadjuvant therapy for muscle-invasive bladder cancer.
Academic Article Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Academic Article Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Academic Article A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Academic Article Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?
Search Criteria
  • Cancer
  • immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.